Mesirow Financial Investment Management Equity & Fixed Income United Therapeutics Corp Transaction History

Mesirow Financial Investment Management Equity & Fixed Income

$114 Million
Q2 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$166.16 - $213.96 $2.4 Million - $3.09 Million	-14,425 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$184.32 - $216.08 $209,203 - $245,250	1,135 Added 8.54%	14,425 $3.12 Million
Q3 2021 Nov 04, 2021	BUY	$179.86 - $214.88 $190,651 - $227,772	1,060 Added 8.67%	13,290 $2.45 Million
Q2 2021 Aug 03, 2021	SELL	$170.47 - $211.93 $7.54 Million - $9.37 Million	-44,235 Reduced 78.34%	12,230 $2.19 Million
Q1 2021 May 03, 2021	SELL	$153.94 - $174.85 $1.04 Million - $1.18 Million	-6,730 Reduced 10.65%	56,465 $9.45 Million
Q4 2020 Feb 01, 2021	SELL	$101.87 - $151.79 $72,327 - $107,770	-710 Reduced 1.11%	63,195 $9.59 Million
Q3 2020 Nov 05, 2020	BUY	$99.9 - $121.13 $623,875 - $756,456	6,245 Added 10.83%	63,905 $6.45 Million
Q2 2020 Aug 06, 2020	BUY	$92.74 - $125.82 $1.65 Million - $2.24 Million	17,800 Added 44.66%	57,660 $6.98 Million
Q1 2020 Apr 28, 2020	BUY	$79.39 - $115.35 $3.16 Million - $4.6 Million	39,860 New	39,860 $3.78 Million

Others Institutions Holding UTHR

# of Institutions

619

Shares Held

45M

Call Options Held

368K

Put Options Held

410K

Black Rock Inc. New York, NY

5.47M
Shares

$1.93 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.42M
Shares

$1.56 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.29M
Shares

$1.16 Billion
0.19% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.01 Billion
12.43% of portfolio
State Street Corp Boston, MA

2.29M
Shares

$809 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management Equity & Fixed Income, based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management Equity & Fixed Income with notifications on news.

Account